{"pageContent": "Objective: To explore patients' quality of life (QoL) during neoadjuvant hormone therapy (HT) using data from the Medical Research Council RT01 trial of standard- (64 Gy/32-fraction) and high- (74 Gy/37-fraction) dose radiotherapy (RT, both given conformally).", "metaData": {"source": "The struggle towards 'the New Normal': a qualitative insight into psychosexual adjustment to prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/25073798/"}}